|05th December,2018||16:00-17:30||Track 2|
Bringing new therapies to treat rare diseases requires more than scientific innovation. Innovation in business models and incubation financing is critical as the need to find ways to cost effectively develop new medicines becomes increasingly important. Initiatives like collaboration centres and rare disease centres try to take the best of both worlds by implementing multidimensional approaches to address the needs of the rare disease community. In addition to conducting their own research, collaborative models with both pharmaceutical companies, academic institutions, start-ups and patient groups are now put in place.